Intuitive tightens 2026 robotic-surgery procedure growth forecast; shares fall

By Reuters News

By Sahil Pandey

Oct 20 (Reuters) - Intuitive Surgical ISRG.O on Tuesday tightened its 2026 forecast for growth in procedures performed using its da Vinci robotic surgery systems.

Procedure growth is a key measure for Intuitive as surgeries performed using its da Vinci systems generate recurring sales of instruments and accessories, its largest revenue segment.

  • The medical-device maker, whose shares fell about 7% in extended trading, expects worldwide da Vinci procedure growth to be closer to the midpoint of its 14% to 15% forecast range. Its prior view was 13.5% to 15.5%

  • US da Vinci procedure growth was 10% in the third quarter, while growth outside the US was 20%

  • Intuitive plans to roll out its Extended Use Program, designed to reduce instrument costs and broaden access to robotic-assisted surgery, and expects the US to be its first market, pending regulatory clearance

  • Third-quarter adjusted profit was $3 per diluted share on revenue of $3.05 billion, compared with estimates of $2.64 and $2.91 billion, respectively, according to data compiled by LSEG

  • Intuitive continues to monitor lower Affordable Care Act enrollment, changes to Medicaid eligibility and potential changes to the 340B drug-pricing program, CFO Jamie Samath said

  • In July, Intuitive said the expiration of enhanced Affordable Care Act subsidies had a modest adverse impact on US procedure growth

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.